β¨ Clinical Guidelines for Ultrasound in Pregnancy
24 APRIL
NEW ZEALAND GAZETTE
1143
GR Suspected IUGR
If no clinical or objective growth of the foetus over a four week period or a significant decrease in liquor.
MG Monitor growth
To monitor the progress of a foetus where IUGR or macrosomia has been diagnosed or suspected on a previous scan.
PO Clinical polyhydramnios
Fundal height >4cm above mean for dates or clinical suspicion of increased liquor.
PL Check placenta
Moderate/severe hypertension, pre-eclampsia or toxaemia. Significant renal disease, diabetes, cardiac disease, asthma etc.
MI Maternal illness
May need serial scans due to risk of preterm labour and IUGR.
AH Antepartum haemorrhage
Where significant complication of pregnancy is suspected (e.g. abruption).
AP Abdominal pain
May need serial scans to assess liquor volume and foetal growth and well-being.
SR Spontaneous rupture of membranes
After 36 weeks.
MP Malpresentation
To assess foetal size and position.
BR Planned trial of breech delivery
Significant reduction of foetal movements. Biophysical Profile may be appropriate. Prolonged/post-term pregnancy.
FC Suspected foetal compromise
For a clinically indicated scan not conforming to any of the above, but necessary after discussion with the Specialist and annotated accordingly. May include foetal echocardiography (e.g. if family history).
FD Suspected intrauterine foetal death
e.g. Suspected retained products, postpartum haemorrhage, pelvic haematoma.
MU Miscellaneous ultrasound
To assess an abnormality diagnosed during the pregnancy e.g. dilated renal tract, mass, cyst etc.
PP Maternal postpartum
NU Neonatal postpartum
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 40
Gazette.govt.nz —
NZ Gazette 2002, No 40
β¨ LLM interpretation of page content
π₯
Clinical Indications for Ultrasound in Pregnancy
(continued from previous page)
π₯ Health & Social WelfareUltrasound, Pregnancy, Clinical Indications, Obstetrics, Radiology, Foetal Growth, Maternal Health